Literature DB >> 12695534

The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo.

Ramiro Salas1, Avi Orr-Urtreger, Ron S Broide, Arthur Beaudet, Richard Paylor, Mariella De Biasi.   

Abstract

Nicotine, acting at pentameric neuronal nicotinic acetylcholine receptors (nAChRs), is the primary addictive component in tobacco. At low doses, it affects attention, learning, memory, anxiety, cardiovascular responses, thermoregulation, and nociception. At high doses, nicotine produces more drastic behaviors and eventually induces tonic-clonic seizures in rodents. In mammals, several subunits of the nAChRs have been cloned, including eight alpha and three beta subunits. To study the physiological role of the alpha 5 subunit, we have generated alpha 5-deficient mice. These mice have a generally healthy appearance and are normal in a standard battery of behavioral tests. However, the sensitivity of alpha 5 mutant mice to nicotine-induced behaviors and seizures is dramatically reduced compared with their wild-type littermates. These animals have a normal brain anatomy and normal levels of mRNA for other nAChR subunits, namely alpha 4, alpha 6, alpha 7, beta 2, and beta 4. In addition, (125)I-epibatidine and [(125)I]alpha-bungarotoxin binding in the brains of alpha 5-deficient mice is normal. Together, these results suggest a direct involvement of the alpha 5 subunit in the observed phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695534     DOI: 10.1124/mol.63.5.1059

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  97 in total

Review 1.  Is there evidence for potential harm of electronic cigarette use in pregnancy?

Authors:  Melissa A Suter; Joan Mastrobattista; Maike Sachs; Kjersti Aagaard
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-11-04

2.  Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits.

Authors:  Michael K Tian; Craig D C Bailey; Mariella De Biasi; Marina R Picciotto; Evelyn K Lambe
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

3.  Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.

Authors:  Bhagirathi Dash; Ronald J Lukas
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant.

Authors:  Andrew A George; Linda M Lucero; M Imad Damaj; Ronald J Lukas; Xiangning Chen; Paul Whiteaker
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

5.  Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.

Authors:  K J Jackson; M J Marks; R E Vann; X Chen; T F Gamage; J A Warner; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2010-04-16       Impact factor: 4.030

6.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

7.  Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively enhanced maximal effects.

Authors:  Ying Chen; Lisa M Broad; Keith G Phillips; Ruud Zwart
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

Review 9.  New insights into the genetics of addiction.

Authors:  Ming D Li; Margit Burmeister
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

Review 10.  Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds.

Authors:  Jennifer A Wilking; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.